首页/数据集/Table S3 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming

Table S3 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming

Figshare2026-04-01 更新2026-04-28 收录

神经内分泌前列腺癌

血清素通路表观遗传调控

数据链接：

https://figshare.com/articles/dataset/Table_S3_from_Serotonin_Modulates_Lineage_Plasticity_in_Neuroendocrine_Prostate_Cancer_via_Epigenetic_Reprogramming/31911218 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Table S3. 5-HT pathway drugs in high-throughput drug screening

应用场景：

创建时间：

2026-04-01

相关数据集

LTL331_scRNA_seq_Metadata

神经内分泌前列腺癌

时序转录组分析

Neuroendocrine transdifferentiation (NEtD) of prostate adenocarcinoma (PRAD) leads to aggressive neuroendocrine prostate cancer (NEPC). The LTL331 patient-derived xenograft (PDX) model consistently pr

Figshare2025-04-28 更新30

Gene and microRNA expression data from neuroendocrine transdifferentiated and untreated prostate cancer cell line LNCaP. Gene and microRNA expression data from neuroendocrine transdifferentiated and untreated prostate cancer cell line LNCaP

神经内分泌前列腺癌

基因与microRNA表达谱

Prostate tumors contain foci of neuroendocrine transdifferentiation (NETD), resulting in an increase of androgen-independent neuroendocrine-like (NE) tumor cells, whose number significantly correlates

NIAID Data Ecosystem20

Lineage specific chromatin modification guides Pax5 mediated gene expression in neuroendocrine like differentiation of prostate cancer (ChIP-Seq). Lineage specific chromatin modification guides Pax5 mediated gene expression in neuroendocrine like differentiation of prostate cancer (ChIP-Seq)

神经内分泌前列腺癌

染色质调控

Neuroendocrine-like differentiation of castration-resistant prostate cancer is highly aggressive and independent of the androgen receptor signaling for its progression. During such lineage differentia

NIAID Data Ecosystem10

Epigenetic de-repression of drivers of neuroendocrine prostate cancer [RNA-seq]

神经内分泌前列腺癌

表观遗传调控

Epigenetic de-repression of drivers of neuroendocrine prostate cancer RNA-Seq to understand epigenetic de-repression of drivers of neuroendocrine prostate cancer

NIAID Data Ecosystem20

Table3_Specific classification and new therapeutic targets for neuroendocrine prostate cancer: A patient-based, diagnostic study.docx

神经内分泌前列腺癌

癌症治疗靶点

Objective: Neuroendocrine prostate cancer (NEPC) is an aggressive variant of prostate cancer (PC) that may arise de novo or in patients previously treated with hormonal therapies for prostate adenocar

NIAID Data Ecosystem20